+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Teneligliptin"

Insulin Drugs Global Market Report 2024 - Product Thumbnail Image

Insulin Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Global and Chinese Teneligliptin Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Teneligliptin Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 135 Pages
  • China, Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Teneligliptin is a drug used to treat endocrine and metabolic disorders. It is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which works by increasing the levels of incretin hormones in the body. This helps to reduce blood sugar levels in people with type 2 diabetes. Teneligliptin is also used to treat non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS). It is available in tablet form and is usually taken once daily. Teneligliptin is generally well tolerated, with the most common side effects being nausea, headache, and diarrhea. It is important to note that Teneligliptin should not be used in combination with other DPP-4 inhibitors, as this may increase the risk of hypoglycemia. Teneligliptin is marketed by several companies, including AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, and Takeda Pharmaceuticals. Show Less Read more